港股异动 | 春立医疗(01858)一度涨超18% 公司主要产品为骨科医疗器械及组织修复系列产品

智通财经网2025-04-25

春立医疗(01858)早盘一度涨超18%，截至发稿，涨7.17%，报9.71港元，成交额7032.08万港元。消息面上，春立医疗2024年实现营业额8.06亿元人民币，同比跌33.3%；纯利1.25亿元，同比跌55%；每股盈利0.33元。派末期息4.9分。此外，春立医疗制定2024-2026年股东分红回报规划，明确在盈利且累计未分配利润为正的情况下，每年现金分红比例不低于可供股东分配利润的10%。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530928694?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-25 11:03","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2530928694","market":"us","top_or_hot":-1,"title":"港股异动 | 春立医疗(01858)一度涨超18% 公司主要产品为骨科医疗器械及组织修复系列产品","media":"智通财经网","content":"<div>\n<p>春立医疗(01858)早盘一度涨超18%，截至发稿，涨7.17%，报9.71港元，成交额7032.08万港元。消息面上，春立医疗2024年实现营业额8.06亿元人民币，同比跌33.3%；纯利1.25亿元，同比跌55%；每股盈利0.33元。派末期息4.9分。此外，春立医疗制定2024-2026年股东分红回报规划，明确在盈利且累计未分配利润为正的情况下，每年现金分红比例不低于可供股东分配利润的10%。...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-25/doc-ineuivsc2228076.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 春立医疗(01858)一度涨超18% 公司主要产品为骨科医疗器械及组织修复系列产品</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 春立医疗(01858)一度涨超18% 公司主要产品为骨科医疗器械及组织修复系列产品\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-25 11:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-25/doc-ineuivsc2228076.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>春立医疗(01858)早盘一度涨超18%，截至发稿，涨7.17%，报9.71港元，成交额7032.08万港元。消息面上，春立医疗2024年实现营业额8.06亿元人民币，同比跌33.3%；纯利1.25亿元，同比跌55%；每股盈利0.33元。派末期息4.9分。此外，春立医疗制定2024-2026年股东分红回报规划，明确在盈利且累计未分配利润为正的情况下，每年现金分红比例不低于可供股东分配利润的10%。...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-25/doc-ineuivsc2228076.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09997","symbol_name":"康基医疗","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-25/doc-ineuivsc2228076.shtml","article_id":"2530928694","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530928694","pubTimestamp":1745550180,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"春立医疗早盘一度涨超18%，截至发稿，涨7.17%，报9.71港元，成交额7032.08万港元。春立医疗主要产品为骨科医疗器械及组织修复系列产品，包括脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品以及富血小板血浆制备用套装和封闭创伤负压引流套装等。据悉，富血小板血浆 是血小板和血浆的浓缩物，富含生长因子，发挥着重要的抗炎修复和组织再生的作用，近年来被逐渐应用于美容医学领域。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","688236":"春立医疗","09997":"康基医疗","BK1100":"医疗保健设备","BK0251":"专用设备","01858":"春立医疗","BK1585":"昨日强势股","BK1583":"高瓴概念","BK1574":"生物医药B类股","BK1222":"医疗保健用品","09996":"沛嘉医疗-B"},"translate_title":"Changes in Hong Kong stocks Chunli Medical (01858) once rose more than 18% The company's main products are orthopedic medical devices and tissue repair products","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"688236":1,"01858":1,"09997":1,"09996":1},"content_text":"春立医疗(01858)早盘一度涨超18%，截至发稿，涨7.17%，报9.71港元，成交额7032.08万港元。消息面上，春立医疗2024年实现营业额8.06亿元人民币，同比跌33.3%；纯利1.25亿元，同比跌55%；每股盈利0.33元。派末期息4.9分。此外，春立医疗制定2024-2026年股东分红回报规划，明确在盈利且累计未分配利润为正的情况下，每年现金分红比例不低于可供股东分配利润的10%。春立医疗主要产品为骨科医疗器械及组织修复系列产品，包括脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品以及富血小板血浆(PRP)制备用套装和封闭创伤负压引流套装等。据悉，富血小板血浆 (PRP)是血小板和血浆的浓缩物，富含生长因子，发挥着重要的抗炎修复和组织再生的作用，近年来被逐渐应用于美容医学领域。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease,movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530928694","isCrawlerRequest":true}